Medtronic (MDT) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Medtronic Revenue Highlights

Latest Revenue (Y)

$32.36B

Latest Revenue (Q)

$7.92B

Main Segment (Y)

Cardiac and Vascular Group

Main Geography (Y)

Japan, Australia, New Zealand, Korea, Canada, and Western Europe

Medtronic Revenue by Period

Medtronic Revenue by Year

Date	Revenue	Change
2024-04-26	$32.36B	3.64%
2023-04-28	$31.23B	-1.45%
2022-04-29	$31.69B	5.21%
2021-04-30	$30.12B	4.16%
2020-04-24	$28.91B	-5.38%
2019-04-26	$30.56B	2.02%
2018-04-27	$29.95B	0.82%
2017-04-28	$29.71B	3.04%
2016-04-29	$28.83B	42.31%
2015-04-24	$20.26B	19.15%
2014-04-30	$17.00B	2.50%
2013-04-30	$16.59B	2.51%
2012-04-30	$16.18B	1.58%
2011-04-30	$15.93B	0.73%
2010-04-30	$15.82B	8.34%
2009-04-30	$14.60B	8.02%
2008-04-30	$13.52B	9.89%
2007-04-30	$12.30B	8.92%
2006-04-30	$11.29B	12.31%
2005-04-30	$10.05B	10.65%
2004-04-30	$9.09B	18.55%
2003-04-30	$7.67B	19.57%
2002-04-30	$6.41B	15.47%
2001-04-30	$5.55B	10.71%
2000-04-30	$5.01B	21.30%
1999-04-30	$4.13B	58.71%
1998-04-30	$2.60B	6.83%
1997-04-30	$2.44B	12.41%
1996-04-30	$2.17B	24.49%
1995-04-30	$1.74B	25.27%
1994-04-30	$1.39B	-

Medtronic generated $32.36B in revenue during NA 2024, up 3.64% compared to the previous quarter, and up 105.91% compared to the same period a year ago.

Medtronic Revenue by Quarter

Date	Revenue	Change
2024-07-26	$7.92B	-7.85%
2024-04-26	$8.59B	6.18%
2024-01-26	$8.09B	1.32%
2023-10-27	$7.98B	3.66%
2023-07-28	$7.70B	-9.85%
2023-04-28	$8.54B	10.57%
2023-01-27	$7.73B	1.87%
2022-10-28	$7.58B	2.90%
2022-07-29	$7.37B	-8.88%
2022-04-29	$8.09B	4.20%
2022-01-28	$7.76B	-1.07%
2021-10-29	$7.85B	-1.75%
2021-07-30	$7.99B	-2.45%
2021-04-30	$8.19B	5.31%
2021-01-29	$7.78B	1.67%
2020-10-30	$7.65B	17.52%
2020-07-31	$6.51B	8.49%
2020-04-24	$6.00B	-22.28%
2020-01-24	$7.72B	0.14%
2019-10-25	$7.71B	2.84%
2019-07-26	$7.49B	-8.02%
2019-04-26	$8.15B	7.95%
2019-01-25	$7.55B	0.87%
2018-10-26	$7.48B	1.31%
2018-07-27	$7.38B	-9.33%
2018-04-27	$8.14B	10.52%
2018-01-26	$7.37B	4.52%
2017-10-27	$7.05B	-4.60%
2017-07-28	$7.39B	-6.64%
2017-04-28	$7.92B	8.69%
2017-01-27	$7.28B	-0.84%
2016-10-28	$7.34B	2.50%
2016-07-29	$7.17B	-5.30%
2016-04-29	$7.57B	9.13%
2016-01-29	$6.93B	-1.76%
2015-10-30	$7.06B	-2.97%
2015-07-31	$7.27B	-0.41%
2015-04-24	$7.30B	69.15%
2015-01-23	$4.32B	-1.10%
2014-10-31	$4.37B	2.18%
2014-07-31	$4.27B	-6.40%
2014-04-30	$4.57B	9.66%
2014-01-31	$4.16B	-0.74%
2013-10-31	$4.19B	2.72%
2013-07-31	$4.08B	-8.45%
2013-04-30	$4.46B	10.75%
2013-01-31	$4.03B	-1.66%
2012-10-31	$4.09B	2.17%
2012-07-31	$4.01B	-6.73%
2012-04-30	$4.30B	9.67%
2012-01-31	$3.92B	-5.18%
2011-10-31	$4.13B	2.05%
2011-07-31	$4.05B	-5.73%
2011-04-30	$4.29B	8.43%
2011-01-31	$3.96B	1.49%
2010-10-31	$3.90B	3.45%
2010-07-31	$3.77B	-10.08%
2010-04-30	$4.20B	8.96%
2010-01-31	$3.85B	0.34%
2009-10-31	$3.84B	-2.42%
2009-07-31	$3.93B	2.72%
2009-04-30	$3.83B	9.59%
2009-01-31	$3.49B	-2.13%
2008-10-31	$3.57B	-3.67%
2008-07-31	$3.71B	-3.99%
2008-04-30	$3.86B	13.36%
2008-01-31	$3.40B	-

Medtronic generated $7.92B in revenue during Q1 2025, up -7.85% compared to the previous quarter, and up 92.64% compared to the same period a year ago.

Medtronic Revenue Breakdown

Medtronic Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Apr 24	Apr 23	Apr 22	Apr 21	Apr 20
Diabetes Group	$2.49B	$2.26B	-	-	-
Cardiac and Vascular Group	$11.83B	$11.57B	$5.06B	-	-
Medical Surgical	$8.42B	$8.43B	-	-	-
Neuroscience Group	$9.41B	$8.96B	-	-	-
Neuroscience Portfolio	-	$8.96B	$5.75B	$5.46B	-
Medical Surgical Portfolio	-	$8.43B	$3.86B	$3.65B	-
Diabetes Operating Unit	-	$2.26B	-	-	-
Cardiovascular	-	$11.57B	$5.54B	-	-
Cardiovascular Portfolio	-	-	-	$141.00M	-
Restorative Therapies Group	-	-	-	-	$5.12B
Minimally Invasive Therapies Group	-	-	-	-	$3.53B

Medtronic's latest annual revenue breakdown by segment (product or service), as of Apr 24: Cardiac and Vascular Group (36.81%), Neuroscience Group (29.26%), Medical Surgical (26.19%), and Diabetes Group (7.74%).

Quarterly Revenue by Product

Product/Service	Jul 24	Apr 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20	Oct 19	Jul 19	Apr 19
Neuroscience Group	$2.32B	$4.90B	$2.29B	$4.44B	$1.51B	$1.51B	$1.42B	$1.40B	$1.39B	$1.45B	-	-	-	-	-	-	-	-	-	-
Diabetes Group	$647.00M	$947.00M	$963.00M	$1.16B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiac and Vascular Group	$3.01B	$6.06B	$1.27B	$1.38B	$1.21B	$880.00M	$1.37B	$1.46B	$1.36B	$1.51B	-	-	-	-	-	-	-	-	-	-
Medical Surgical	$2.00B	$4.24B	$2.14B	$4.08B	$965.00M	$905.00M	$843.00M	$990.00M	$970.00M	$990.00M	-	-	-	-	-	-	-	-	-	-
Other	-	-	$22.00M	$32.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiovascular	-	-	$2.92B	$5.70B	$9.23B	$1.38B	$1.42B	$1.30B	$1.46B	$1.30B	$1.37B	$1.42B	-	-	-	-	-	-	-	-
Minimally Invasive Therapies Group	-	-	-	-	-	-	-	-	-	-	-	-	$959.00M	$996.00M	$722.00M	$763.00M	$934.00M	$922.00M	$913.00M	$971.00M
Restorative Therapies Group	-	-	-	-	-	-	-	-	-	-	-	-	$1.40B	$1.40B	$1.14B	$935.00M	$1.41B	$1.44B	$1.34B	$1.47B

Medtronic's latest quarterly revenue breakdown by segment (product or service), as of Jul 24: Cardiac and Vascular Group (37.74%), Neuroscience Group (29.08%), Medical Surgical (25.05%), and Diabetes Group (8.12%).

Medtronic Revenue Breakdown by Country

Annual Revenue by Country

Country	Apr 24	Apr 23	Apr 22	Apr 21	Apr 20
Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea	$5.82B	$5.45B	-	-	-
Japan, Australia, New Zealand, Korea, Canada, and Western Europe	$9.98B	$9.41B	-	-	-
Total Other Countries, Excluding United States and Ireland	-	$14.76B	$15.45B	$14.49B	$13.91B
Total Other Countries, Excluding Ireland	-	$31.13B	$31.59B	$30.02B	$28.83B
IRELAND	-	$98.00M	$101.00M	$100.00M	$85.00M
Medical Surgical Portfolio	-	-	$3.86B	-	-
Cardiovascular	-	-	$5.54B	-	-
Neuroscience Portfolio	-	-	$5.75B	-	-

Medtronic's latest annual revenue breakdown by geography, as of Apr 24: Japan, Australia, New Zealand, Korea, Canada, and Western Europe (63.15%), and Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea (36.85%).

Quarterly Revenue by Country

Country	Jul 24	Apr 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20	Oct 19	Jul 19
IRELAND	$30.00M	$29.00M	$29.00M	$27.00M	$23.00M	$25.00M	$23.00M	$25.00M	$24.00M	$27.00M	$26.00M	$26.00M	$25.00M	$24.00M	$24.00M	$19.00M	$22.00M	$23.00M	$20.00M	-
UNITED STATES	$4.08B	$4.18B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Japan, Australia, New Zealand, Korea, Canada, and Western Europe	-	$5.15B	$2.37B	$2.67B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea	-	$3.07B	$1.44B	$1.33B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Other Countries, Excluding Ireland	-	-	$7.96B	$7.67B	$8.52B	$7.70B	$7.56B	$7.35B	$8.06B	$7.74B	$7.82B	$7.96B	$8.16B	$7.75B	$7.62B	$6.48B	$5.98B	$7.70B	$7.68B	$7.47B
Total Other Countries, Excluding United States and Ireland	-	-	$3.78B	$3.75B	$4.04B	$3.64B	$3.49B	$3.58B	$3.97B	$3.80B	$3.82B	$3.86B	$3.98B	$3.81B	$3.57B	$3.13B	$3.13B	$3.67B	$3.55B	$3.56B
Medical Surgical	-	-	-	-	-	$965.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Neuroscience Group	-	-	-	-	-	$1.51B	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiovascular	-	-	-	-	-	$1.38B	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Medtronic's latest quarterly revenue breakdown by geography, as of Jul 24: UNITED STATES (99.27%), and IRELAND (0.73%).

Medtronic Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ABT	Abbott Laboratories	$40.11B	$10.63B
MDT	Medtronic	$32.36B	$7.92B
SYK	Stryker	$20.50B	$5.49B
EW	Edwards Lifesciences	$6.00B	$1.35B
ALGN	Align	$3.86B	$977.87M
DXCM	DexCom	$3.62B	$994.20M
ZBH	Zimmer Biomet	$1.94B	$143.40M
PODD	Insulet	$1.70B	$372.60M
TNDM	Tandem Diabetes Care	$747.72M	$221.91M

MDT Revenue FAQ

What is Medtronic’s yearly revenue?

Medtronic's yearly revenue for 2024 was $32.36B, representing an increase of 3.64% compared to 2023. The company's yearly revenue for 2023 was $31.23B, representing a decrease of -1.45% compared to 2022. MDT's yearly revenue for 2022 was $31.69B, representing an increase of 5.21% compared to 2021.

What is Medtronic’s quarterly revenue?

Medtronic's quarterly revenue for Q1 2025 was $7.92B, a -7.85% decrease from the previous quarter (Q4 2024), and a 2.77% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $8.59B, a 6.18% increase from the previous quarter (Q3 2024), and a 0.53% increase year-over-year (Q4 2023). MDT's quarterly revenue for Q3 2024 was $8.09B, a 1.32% increase from the previous quarter (Q2 2024), and a 4.68% increase year-over-year (Q3 2023).

What is Medtronic’s revenue growth rate?

Medtronic's revenue growth rate for the last 3 years (2022-2024) was 2.14%, and for the last 5 years (2020-2024) was 11.94%.

What are Medtronic’s revenue streams?

Medtronic's revenue streams in r 24 are Diabetes Group, Cardiac and Vascular Group, Medical Surgical, and Neuroscience Group. Diabetes Group generated $2.49B in revenue, accounting 7.74% of the company's total revenue, up 9.99% year-over-year. Cardiac and Vascular Group generated $11.83B in revenue, accounting 36.81% of the company's total revenue, up 2.23% year-over-year. Medical Surgical generated $8.42B in revenue, accounting 26.19% of the company's total revenue, down -0.19% year-over-year. Neuroscience Group generated $9.41B in revenue, accounting 29.26% of the company's total revenue, up 4.99% year-over-year.

What is Medtronic’s main source of revenue?

For the fiscal year ending Apr 24, the largest source of revenue of Medtronic was Cardiac and Vascular Group. This segment made a revenue of $11.83B, representing 36.81% of the company's total revenue.